4 Results for "

DDC-01-163

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "DDC-01-163" in MCE Product Catalog:

Cat. No.: HY-139997
CAS No.: 2140806-84-2
Target:  

PROTACs EGFR

Research Areas:  

Cancer

DDC-01-163 is an allosteric PROTAC degrader targeting EGFR. DDC-01-163 is dependent on the ubiquitin–proteasome system. DDC-01-163 can selectively inhibit the proliferation of L858R/T790M (L/T) mutant Ba/F3 cells. DDC-01-163 is effective against Osimertinib (HY-15772)-resistant cells with L/T/C797S and L/T/L718Q EGFR mutations. DDC-01-163 exhibits enhanced anti-proliferative activity against L858R/T790M EGFR-Ba/F3 cells when combined with the ATP-site EGFR inhibitor Osimertinib. DDC-01-163 can be used for the study of non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-151048
CAS No.: 2140807-58-3
Target:  

EGFR

Research Areas:  

Cancer

JBJ-07-149 is an inhibitor for EGFRL858R/T790M with an IC50 of 1.1 nM. JBJ-07-149 inhibits the proliferation of cell Ba/F3 with IC50 of 4.9 μM and 0.148 μM, without and with presence of Cetuximab (HY-P9905). JBJ-07-149 can be used as ligand for target protein in synthesis of DDC-01-163 (HY-139997) .
loading...
    loading...
Cat. No.: HY-170351
Target:  

PROTAC Linkers

Research Areas:  

Cancer

NH2-PEG2-OMs is the linker, that could be used for synthesis of PROTAC degrader DDC-01-163 (HY-139997) .
loading...
    loading...
Cat. No.: HY-170350
CAS No.: 2140807-37-8
Research Areas:  

Cancer

Pomalidomide-PEG2-Oms (CRBN ligand Pomalidomide (HY-10984)) is an E3 Ligase Ligand-Linker Conjugate for EGFR PROTAC DDC-01-163 (HY-139997) .
loading...
    loading...